Press "Enter" to skip to content

UK healthcare cost agency rejects J&J’s nasal spray for depression

Britain’s healthcare cost agency on Tuesday recommended against including Johnson & Johnson’s nasal spray for depression, Spravato, in the country’s healthcare network, citing uncertainties over its clinical and cost effectiveness.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/rwoEjGgxEcc/uk-healthcare-cost-agency-rejects-jjs-nasal-spray-for-depression-idINKBN1ZR017